导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 3.26% | 435/1050 |
| 近一周 | -6.71% | 1097/1104 |
| 近一月 | 0.30% | 73/1102 |
| 近一季 | -2.50% | 347/1092 |
| 近半年 | -10.55% | 780/1070 |
| 近一年 | 19.44% | 243/1018 |
| 近两年 | 44.33% | 543/926 |
| 近三年 | 36.62% | 344/834 |
| 成立以来 | 126.61% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
3.38% 235/1070 |
-2.07% 735/1101 |
- - |
- - |
| 2025 | 42.35% 290/1065 |
4.58% 439/1014 |
0.01% 683/1038 |
22.82% 511/1050 |
10.82% 38/1065 |
| 2024 | -0.45% 593/1011 |
18.89% 1/960 |
1.49% 216/983 |
0.25% 954/991 |
-17.71% 984/1011 |
| 2023 | -10.25% 338/952 |
0.71% 593/880 |
-9.87% 766/895 |
2.47% 28/915 |
-3.50% 375/952 |
| 2022 | -35.43% 706/867 |
-23.72% 693/773 |
16.22% 87/806 |
-16.04% 619/845 |
-13.25% 827/867 |
| 2021 | 22.96% 133/740 |
-0.12% 156/580 |
11.18% 325/659 |
20.42% 15/704 |
-8.04% 637/740 |
| 2020 | 67.58% 152/554 |
-0.59% 175/419 |
23.84% 212/466 |
19.33% 62/517 |
14.07% 226/554 |
| 2019 | 38.57% 231/410 |
15.50% 1001/1146 |
0.09% 324/1228 |
0.91% 311/390 |
18.78% 20/410 |
| 2018 | -18.54% 53/349 |
- - |
-3.59% 153/990 |
-4.11% 422/1000 |
-7.80% 139/1080 |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8316 | 54.00% |
| 招商前沿医疗保健股票C | 0.7978 | 53.69% |
| 招商医药健康产业股票 | 2.5730 | 48.73% |
| 嘉实医疗保健股票 | 2.5780 | 39.05% |
| 广发医药精选股票A | 1.3132 | 38.48% |
| 广发医药精选股票C | 1.2923 | 38.32% |
| 前海开源公共卫生股票A | 0.4690 | 37.42% |
| 前海开源公共卫生股票C | 0.4590 | 37.30% |
| 交银医药创新股票C | 3.0594 | 35.86% |
| 交银医药创新股票A | 2.8810 | 32.85% |
| 广发资源优选股票A VS. 东吴新产业精选股票A(580008) |